Literature DB >> 15879867

Clinical features and immunoexpression of p53, MIB-1 and proliferating cell nuclear antigen in adrenal neoplasms.

Antonio C P Martins1, Adauto J Cologna, Silvio Tucci, Haylton J Suaid, Rodrigo A R Falconi.   

Abstract

PURPOSE: We evaluated the clinical features and immunoreactivity of p53 protein, MIB-1 antigen and proliferating cell nuclear antigen (PCNA) in adrenal neoplasms.
MATERIALS AND METHODS: A total of 26 patients with adrenocortical adenoma and 24 patients with carcinoma were treated with adrenalectomy. Clinical features and immunohistochemical reactions were compared in adult vs pediatric tumors.
RESULTS: There was a bimodal age distribution of carcinomas and adenomas, with a first peak occurring before age 5 years. The proportion of carcinomas in children (18 of 29) was higher than in adults (6 of 21). Carcinoma and adenoma occurring in children presented more commonly as the virilizing syndrome, while in adults Cushing's syndrome was more common. All adenomas in adults were p53 negative, while in children 4 of 11 adenomas (36%) were p53 positive. Histological Weiss criteria were the most reliable pathological features to distinguish adenoma from carcinoma. Other pathological features, including tumor weight, rate of mitotic figures and immunoexpression of p53 protein, MIB-1 antigen and PCNA, exhibited a striking difference in adenomas and carcinomas but none demonstrated sensitivity or specificity of 100%. Of all the computerized tomographic characteristics analyzed, including tumor size, shape, necrosis/hemorrhage, attenuation and contrast enhancement, only tumor size (greater than 5 cm) showed sensitivity and specificity of 100% in the differential diagnosis. Children and adults with carcinoma had similar curves of survival (p = 0.76). Carcinoma stage and PCNA immunoexpression displayed an association with outcome.
CONCLUSIONS: Endocrine syndromes differed in adults and children but other clinical features were similar in both groups. The role of p53 protein, MIB-1 antigen and proliferating cell nuclear antigen in discrimination of adenomas from carcinomas is unclear.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15879867     DOI: 10.1097/01.ju.0000157683.55748.41

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

Review 1.  Assessment of malignancy in adrenal cortical tumors.

Authors:  Anne Marie McNicol
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

2.  Histone mRNA in situ hybridization and Ki 67 immunohistochemistry in pediatric adrenocortical tumors.

Authors:  Diclehan Orhan; Gülsev Kale; Melda Cağlar; Safiye Göğüş; Ergun Karaağaoğlu
Journal:  Virchows Arch       Date:  2006-02-18       Impact factor: 4.064

Review 3.  Laparoscopic Trans-Abdominal Right Adrenalectomy for a Large Primitive Adrenal Oncocytic Carcinoma: A Case Report and Review of Literature.

Authors:  Valerio Panizzo; Barbara Rubino; Guglielmo Niccolò Piozzi; Paolo Ubiali; Anna Morandi; Marco Nencioni; Giancarlo Micheletto
Journal:  Am J Case Rep       Date:  2018-09-15

Review 4.  Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma.

Authors:  Hironobu Sasano; Takashi Suzuki; Takuya Moriya
Journal:  Endocr Pathol       Date:  2006       Impact factor: 4.056

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.